Lactate dehydrogenase-to-lymphocyte ratio represents a powerful prognostic tool of metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors
T Li, H Li, S Xie, Y Tan, ZP Xie, WY Li, F Ai - Pathology & Oncology …, 2020 - Springer
Inflammation parameters were verified to predict clinical outcomes of metastatic renal cell
carcinoma (mRCC) patients treated with tyrosine kinase inhibitors (TKIs). Here, we …
carcinoma (mRCC) patients treated with tyrosine kinase inhibitors (TKIs). Here, we …